Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization Sort descending
Jun
28
2017
Opioid Crisis Initiating New State Gift Ban Laws: Maine
May
17
2018
Drinking and Driving: How Driverless Cars Will Overturn South Dakota v. Dole to Push the Drinking Age Back to 18
Mar
15
2016
PTAB Institutes Kyle Bass IPRs Against Juxtapid Patents
Mar
2
2020
Florida Medical Marijuana Users May Soon Become Protected Class Under State Employment Laws
Mar
11
2022
FDA Publishes Proposed Rule on National Standards for The Licensure of Wholesale Drug Distributors and Third-Party Logistics Providers as Required by The Drug Supply Chain Security Act
Mar
29
2020
Whistleblower Suit Against Pharmaceutical Company Heads to Trial
Apr
3
2020
COVID-19: Notable Impacts for Post-Acute Providers from the CARES Act, CMS Blanket Waivers, and the CMS Interim Final Rule
May
26
2022
Will FDA’s Proposed Ban on Flavored Tobacco Products Ever be Implemented?
Jan
9
2017
FDA Releases Biosimilar Guidance for Industry
Feb
23
2023
THC-Oh No! The DEA Classifies Delta-8 and Delta-9 THCO as Controlled Substances
Dec
29
2015
Don't Blame Patents For High Drug Prices
Dec
23
2021
Vaping Will Not Make You Well
Jan
3
2017
EPO Stays Proceedings Over Patentability Of Plants And Animals
Apr
30
2018
This Week in Health Care Policy
Jun
22
2015
Colorado Supreme Court Plays Debbie Downer for Medical Pot Users
Feb
14
2022
Top Trends in Tech-Enabled Home Care
Feb
10
2016
PTAB Institutes Trial On Previously Challenged Cabilly Patent
Dec
28
2021
FDA Issues Latest Draft Guidance on the Use of Real-World Data and Evidence to Support Regulatory Decision-Making for Drug and Biological Products
Nov
23
2020
A Record-Breaking Year in Digital Health Investments: Key Takeaways | HTLH GoLive Webinar
May
14
2013
Environmental Protection Agency (EPA) Establishes June 30 Deadline for Oil and Natural Gas Companies’ Submittal of Requests for Alternative Greenhouse Gas Monitoring Methods
Jan
7
2019
“Pathways to Success:” CMS Publishes Final Rule Modifying the Medicare Shared Savings Program
Jun
19
2019
Your Next Hamburger Could Be "Slaughter-Free"
Feb
11
2015
House To Consider Keystone, Tax Extenders; Senate To Vote On Director Of National Drug Control Policy
May
21
2015
Patent Safe Harbor Applies To Supplemental New Drug Applications
Apr
10
2020
COVID-19: DEA and SAMHSA Guidance for Treating Opioid Use Disorders via Telehealth
Sep
19
2022
New California Bill Protects Employees’ Off-Duty Marijuana Use
Jan
17
2017
Massachusetts Has Legalized Marijuana — Should Your Workplace Policies Go Up in Smoke?
Mar
1
2023
North Carolina Senate Passes Compassionate Care Act – at Exactly 4:20 p.m.
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins